Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Meta-analysis of placebo group dropout in adult antidepressant trials.

Li F, Nasir M, Olten B, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Nov 4:109777. doi: 10.1016/j.pnpbp.2019.109777. [Epub ahead of print] Review.

PMID:
31697973
2.

Randomized, Sham-Controlled Trial of Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Tics in Adolescents With Tourette Syndrome.

Sukhodolsky DG, Walsh C, Koller WN, Eilbott J, Rance M, Fulbright RK, Zhao Z, Bloch MH, King R, Leckman JF, Scheinost D, Pittman B, Hampson M.

Biol Psychiatry. 2019 Aug 13. pii: S0006-3223(19)31590-2. doi: 10.1016/j.biopsych.2019.07.035. [Epub ahead of print]

PMID:
31668476
3.

Selective Serotonin Reuptake Inhibitor Use During Pregnancy-Associated With but Not Causative of Autism in Offspring.

Flores JM, Avila-Quintero VJ, Bloch MH.

JAMA Psychiatry. 2019 Oct 2. doi: 10.1001/jamapsychiatry.2019.2193. [Epub ahead of print] No abstract available.

PMID:
31577332
4.

Meta-Analysis of Placebo Response in Adult Antidepressant Trials.

Li F, Nasir M, Olten B, Bloch MH.

CNS Drugs. 2019 Oct 1. doi: 10.1007/s40263-019-00662-y. [Epub ahead of print] Review.

PMID:
31573058
5.

Antidepressants for Pediatric Patients.

Dwyer JB, Bloch MH.

Curr Psychiatr. 2019 Sep;18(9):26-42F. No abstract available.

6.

Trim the fat: the role of omega-3 fatty acids in psychopharmacology.

Nasir M, Bloch MH.

Ther Adv Psychopharmacol. 2019 Aug 27;9:2045125319869791. doi: 10.1177/2045125319869791. eCollection 2019. Review.

7.

Meta-analysis: Adulthood prevalence of Tourette syndrome.

Levine JLS, Szejko N, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109675. doi: 10.1016/j.pnpbp.2019.109675. Epub 2019 Jun 18. Review.

PMID:
31220521
8.

The impact of attention deficit hyperactivity disorder in obsessive-compulsive disorder subjects.

Blanco-Vieira T, Santos M, Ferrão YA, Torres AR, Miguel EC, Bloch MH, Leckman JF, do Rosario MC.

Depress Anxiety. 2019 Jun;36(6):533-542. doi: 10.1002/da.22898. Epub 2019 Apr 16.

PMID:
30990937
9.

The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.

Artukoglu BB, Bloch MH.

CNS Drugs. 2019 May;33(5):417-430. doi: 10.1007/s40263-019-00627-1.

PMID:
30977108
10.

Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing Reassurance.

Higgins-Chen AT, Abdallah SB, Dwyer JB, Kaye AP, Angarita GA, Bloch MH.

Front Psychiatry. 2019 Mar 22;10:150. doi: 10.3389/fpsyt.2019.00150. eCollection 2019.

11.

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis.

Dobson ET, Bloch MH, Strawn JR.

J Clin Psychiatry. 2019 Jan 29;80(1). pii: 17r12064. doi: 10.4088/JCP.17r12064.

12.

Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.

Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH.

Depress Anxiety. 2019 Mar;36(3):198-212. doi: 10.1002/da.22854. Epub 2018 Nov 26.

PMID:
30479005
13.

Identifying standardized definitions of treatment response in trichotillomania: A meta-analysis.

Farhat LC, Olfson E, Li F, Telang S, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:446-455. doi: 10.1016/j.pnpbp.2018.10.009. Epub 2018 Oct 16.

PMID:
30336171
14.

Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD).

Banaschewski T, Belsham B, Bloch MH, Ferrin M, Johnson M, Kustow J, Robinson S, Zuddas A.

Nutr Health. 2018 Jan 1:260106018772170. doi: 10.1177/0260106018772170. [Epub ahead of print]

15.

Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study.

Taylor JH, Jakubovski E, Gabriel D, Bloch MH.

J Child Adolesc Psychopharmacol. 2018 Sep;28(7):474-484. doi: 10.1089/cap.2017.0147. Epub 2018 Jun 19.

16.

Editorial: Can omega-3 fatty acids improve executive functioning? Will this reduce ADHD and depression?

Artukoglu BB, Bloch MH.

J Child Psychol Psychiatry. 2018 Jun;59(6):615-617. doi: 10.1111/jcpp.12932.

PMID:
29808491
17.

Special Editorial: Open science and the Journal of Child Psychology & Psychiatry - next steps?

Asarnow J, Bloch MH, Brandeis D, Alexandra Burt S, Fearon P, Fombonne E, Green J, Gregory A, Gunnar M, Halperin JM, Hollis C, Jaffee S, Klump K, Landau S, Lesch KP, Oldehinkel AJT, Peterson B, Ramchandani P, Sonuga-Barke E, Stringaris A, Zeanah CH.

J Child Psychol Psychiatry. 2018 Jul;59(7):826-827. doi: 10.1111/jcpp.12929. Epub 2018 May 28.

PMID:
29806217
18.

A Systematic Review of Pharmacologic Treatments for School Refusal Behavior.

Londono Tobon A, Reed MO, Taylor JH, Bloch MH.

J Child Adolesc Psychopharmacol. 2018 Jul/Aug;28(6):368-378. doi: 10.1089/cap.2017.0160. Epub 2018 May 9.

PMID:
29741917
19.

Meta-analysis: Second generation antidepressants and headache.

Telang S, Walton C, Olten B, Bloch MH.

J Affect Disord. 2018 Aug 15;236:60-68. doi: 10.1016/j.jad.2018.04.047. Epub 2018 Apr 9. Review.

PMID:
29715610
20.

Meta regression: Relationship between antipsychotic receptor binding profiles and side-effects.

Olten B, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):272-281. doi: 10.1016/j.pnpbp.2018.01.023. Epub 2018 Feb 2.

PMID:
29410000
21.

Meta-analysis: Risk of dry mouth with second generation antidepressants.

Cappetta K, Beyer C, Johnson JA, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):282-293. doi: 10.1016/j.pnpbp.2017.12.012. Epub 2017 Dec 20. Review.

PMID:
29274375
22.

The conception of the ABCD study: From substance use to a broad NIH collaboration.

Volkow ND, Koob GF, Croyle RT, Bianchi DW, Gordon JA, Koroshetz WJ, Pérez-Stable EJ, Riley WT, Bloch MH, Conway K, Deeds BG, Dowling GJ, Grant S, Howlett KD, Matochik JA, Morgan GD, Murray MM, Noronha A, Spong CY, Wargo EM, Warren KR, Weiss SRB.

Dev Cogn Neurosci. 2018 Aug;32:4-7. doi: 10.1016/j.dcn.2017.10.002. Epub 2017 Oct 10. Review.

23.

Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis.

Wilkinson ST, Sanacora G, Bloch MH.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 May;2(4):327-335. doi: 10.1016/j.bpsc.2017.01.011. Epub 2017 Feb 5.

24.

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.

Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A, Sos P, Wang G, Zarate CA Jr, Sanacora G.

Am J Psychiatry. 2018 Feb 1;175(2):150-158. doi: 10.1176/appi.ajp.2017.17040472. Epub 2017 Oct 3. Review.

25.

Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study.

Taylor JH, Lebowitz ER, Jakubovski E, Coughlin CG, Silverman WK, Bloch MH.

J Clin Child Adolesc Psychol. 2018 Mar-Apr;47(2):266-281. doi: 10.1080/15374416.2017.1371028. Epub 2017 Sep 28.

26.

Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.

Beyer C, Cappetta K, Johnson JA, Bloch MH.

Depress Anxiety. 2017 Dec;34(12):1134-1146. doi: 10.1002/da.22680. Epub 2017 Sep 7.

PMID:
28881483
27.

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial.

Taylor JH, Landeros-Weisenberger A, Coughlin C, Mulqueen J, Johnson JA, Gabriel D, Reed MO, Jakubovski E, Bloch MH.

Neuropsychopharmacology. 2018 Jan;43(2):325-333. doi: 10.1038/npp.2017.194. Epub 2017 Aug 29.

28.

Efficacy of antipsychotics for irritability and aggression in children: a meta-analysis.

van Schalkwyk GI, Lewis AS, Beyer C, Johnson J, van Rensburg S, Bloch MH.

Expert Rev Neurother. 2017 Oct;17(10):1045-1053. doi: 10.1080/14737175.2017.1371012. Epub 2017 Sep 11.

PMID:
28847182
29.

Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder.

Johnson JA, Jakubovski E, Reed MO, Bloch MH.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):747-754. doi: 10.1089/cap.2017.0025. Epub 2017 Aug 3.

30.

Antipsychotics for aggression in adults: A meta-analysis.

van Schalkwyk GI, Beyer C, Johnson J, Deal M, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:452-458. doi: 10.1016/j.pnpbp.2017.07.019. Epub 2017 Jul 25. Review.

PMID:
28754408
31.

Deep Brain Stimulation for Obsessive-Compulsive Disorder-Reply.

Hirschtritt ME, Bloch MH, Mathews CA.

JAMA. 2017 Jul 25;318(4):393. doi: 10.1001/jama.2017.7873. No abstract available.

PMID:
28742903
32.

Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis.

Artukoglu BB, Beyer C, Zuloff-Shani A, Brener E, Bloch MH.

Pain Physician. 2017 Jul;20(5):353-362. Review.

33.

Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.

Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH.

J Clin Psychiatry. 2017 Jun;78(6):e648-e655. doi: 10.4088/JCP.15r10601.

PMID:
28682529
34.

Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.

Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH, Miguel EC, Shavitt RG.

J Clin Psychiatry. 2017 Jul;78(7):e766-e773. doi: 10.4088/JCP.16m11101.

PMID:
28617566
35.

Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.

Gabriel D, Jakubovski E, Taylor JH, Artukoglu BB, Bloch MH.

Psychiatry Res. 2017 Sep;255:248-255. doi: 10.1016/j.psychres.2017.05.038. Epub 2017 May 30.

PMID:
28595147
37.

The efficacy of benzodiazepines as acute anxiolytics in children: A meta-analysis.

Kuang H, Johnson JA, Mulqueen JM, Bloch MH.

Depress Anxiety. 2017 Oct;34(10):888-896. doi: 10.1002/da.22643. Epub 2017 May 15.

38.

Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment.

Hirschtritt ME, Bloch MH, Mathews CA.

JAMA. 2017 Apr 4;317(13):1358-1367. doi: 10.1001/jama.2017.2200. Review.

PMID:
28384832
39.

Ketamine as a Treatment for Adolescent Depression: A Case Report.

Dwyer JB, Beyer C, Wilkinson ST, Ostroff RB, Qayyum Z, Bloch MH.

J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):352-354. doi: 10.1016/j.jaac.2017.01.006. No abstract available.

PMID:
28335880
40.

Predictors of Long-Term School-Based Behavioral Outcomes in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder.

Reed MO, Jakubovski E, Johnson JA, Bloch MH.

J Child Adolesc Psychopharmacol. 2017 May;27(4):296-309. doi: 10.1089/cap.2015.0168. Epub 2017 Mar 2.

41.

Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder.

Adams TG, Bloch MH, Pittenger C.

J Clin Psychopharmacol. 2017 Apr;37(2):269-271. doi: 10.1097/JCP.0000000000000659. No abstract available.

42.

Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.

Lewis AS, van Schalkwyk GI, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:45-53. doi: 10.1016/j.pnpbp.2017.01.001. Epub 2017 Jan 5. Review.

43.

Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial.

Coughlin CG, Jakubovski E, Bloch MH.

J Clin Psychiatry. 2016 Oct;77(10):e1262-e1269. doi: 10.4088/JCP.15m10075.

PMID:
27631142
44.

Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.

Varigonda AL, Jakubovski E, Bloch MH.

J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):851-859.e2. doi: 10.1016/j.jaac.2016.07.768. Epub 2016 Aug 4. Review.

PMID:
27663940
45.

Commentary: Are alpha-2 agonist really effective in children with tics with comorbid ADHD? A commentary on Whittington et al. (2016).

Bloch MH.

J Child Psychol Psychiatry. 2016 Sep;57(9):1005-7. doi: 10.1111/jcpp.12592.

PMID:
27535650
46.

Addressing Difficulties in the Study of Dose-Response Relationships of SSRIs in Depression: Response to Hieronymus and Eriksson.

Jakubovski E, Bloch MH.

Am J Psychiatry. 2016 Aug 1;173(8):836-8. doi: 10.1176/appi.ajp.2016.16030304r. No abstract available.

PMID:
27477138
47.

Editorial: Reducing adolescent suicide.

Bloch MH.

J Child Psychol Psychiatry. 2016 Jul;57(7):773-4. doi: 10.1111/jcpp.12585.

48.

Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.

Issari Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH.

J Clin Psychiatry. 2016 May;77(5):e605-11. doi: 10.4088/JCP.14r09758.

PMID:
27249090
49.

N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.

Bloch MH, Panza KE, Yaffa A, Alvarenga PG, Jakubovski E, Mulqueen JM, Landeros-Weisenberger A, Leckman JF.

J Child Adolesc Psychopharmacol. 2016 May;26(4):327-34. doi: 10.1089/cap.2015.0109. Epub 2016 Mar 30.

50.

Systematic Review of Pharmacological and Behavioral Treatments for Skin Picking Disorder.

Schumer MC, Bartley CA, Bloch MH.

J Clin Psychopharmacol. 2016 Apr;36(2):147-52. doi: 10.1097/JCP.0000000000000462. Review.

Supplemental Content

Loading ...
Support Center